Visual evoked potentials in multiple sclerosis before and after two years of interferon therapy

被引:16
作者
Anlar, O [1 ]
Kisli, M
Tombul, T
Ozbek, H
机构
[1] Yil Univ, Sch Med, Dept Neurol, TR-65200 Van, Turkey
[2] Yil Univ, Dept Pharmacol, TR-65200 Van, Turkey
关键词
interferon; magnetic resonance imaging; multiple sclerosis; visual evoked response;
D O I
10.1080/00207450390162236
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Magnetic resonance imaging (MRI) is important in the diagnosis of and follow-up for the treatment of multiple sclerosis (MS); evoked potentials may be important if MRI is normal or cannot be performed. We assessed serial visual evoked potentials (VEPs) and cranial MRI in a group of clinically relapsing-remitting multiple sclerosis (N = 15) treated with interferon beta-lb (INFB-1b) and in normal subjects (N = 15). The investigations were done I week before INFB-lb therapy, 1 year later (N = 15), and 2 years later (N = 10). VEPs were abnormal in most of the patients; MRIs were abnormal in all patients. We used P100 latency as an electrophysiological index for the progress of illness. There were significant differences in VEPs between the beginning and ending of the interferon treatment. We concluded that VEPs would be a reliable index for following up the progress of MS under interferon therapy.
引用
收藏
页码:483 / 489
页数:7
相关论文
共 20 条
[1]  
Comi G, 1998, J NEUROL NEUROSUR PS, V64, pS21
[2]  
DRISLANE FW, 1994, CLIN NEUROSCI, V2, P196
[3]  
DUQUETTE P, 1995, NEUROLOGY, V45, P1277
[4]   INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DUQUETTE, P ;
GIRARD, M ;
DESPAULT, L ;
DUBOIS, R ;
KNOBLER, RL ;
LUBLIN, FD ;
KELLEY, L ;
FRANCIS, GS ;
LAPIERRE, Y ;
ANTEL, J ;
FREEDMAN, M ;
HUM, S ;
GREENSTEIN, JI ;
MISHRA, B ;
MULDOON, J ;
WHITAKER, JN ;
EVANS, BK ;
LAYTON, B ;
SIBLEY, WA ;
LAGUNA, J ;
KRIKAWA, J ;
PATY, DW ;
OGER, JJ ;
KASTRUKOFF, LF ;
MOORE, GRW ;
HASHIMOTO, SA ;
MORRISON, W ;
NELSON, J ;
GOODIN, DS ;
MASSA, SM ;
GUTTERIDGE, E ;
ARNASON, BGW ;
NORONHA, A ;
REDER, AT ;
MARTIA, R ;
EBERS, GC ;
RICE, GPA ;
LESAUX, J ;
JOHNSON, KP ;
PANITCH, HS ;
BEVER, CT ;
CONWAY, K ;
WALLENBERG, JC ;
BEDELL, L ;
VANDENNOORT, S ;
WEINSHENKER, B ;
WEISS, W ;
REINGOLD, S ;
PACHNER, A ;
TAYLOR, W .
NEUROLOGY, 1993, 43 (04) :655-661
[5]   Evoked potentials for evaluation of multiple sclerosis [J].
Fuhr, P ;
Kappos, L .
CLINICAL NEUROPHYSIOLOGY, 2001, 112 (12) :2185-2189
[6]  
KAJER M, 1987, ELECTROENCEPHALOGR S, V39, P291
[7]  
Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO
[8]  
2-Q
[9]   Medical progress: Multiple sclerosis. [J].
Noseworthy, JH ;
Lucchinetti, C ;
Rodriguez, M ;
Weinshenker, BG .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :938-952
[10]   ASSESSMENT OF MRI CRITERIA FOR A DIAGNOSIS OF MS [J].
OFFENBACHER, H ;
FAZEKAS, F ;
SCHMIDT, R ;
FREIDL, W ;
FLOOH, E ;
PAYER, F ;
LECHNER, H .
NEUROLOGY, 1993, 43 (05) :905-909